Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Immersive virtual reality for upper limb rehabilitation in people with MS: a randomised, controlled feasibility study.

Disability and rehabilitation·2026
Same author

Engineered antibodies bypass bacterial immune evasion to drive complement-mediated protection against lethal infections.

Science translational medicine·2026
Same author

Systemic immune dysregulation in patients experiencing urogynaecological mesh failure.

BJUI compass·2026
Same author

Tragal Cartilage Contouring During Facelift Surgery: A Novel Technique for Prevention of Postoperative Tragal Distortion.

Ophthalmic plastic and reconstructive surgery·2026
Same author

Randomized Controlled Trial of the Psychological and Clinical Outcomes of Reiki Plus Manual Therapy After Open Heart Surgery.

The Journal of cardiovascular nursing·2026
Same author

Postanesthesia Apnea in Former Preterm Infants for Inguinal Herniorrhaphy: An Update of Risk Factors from an Individual Participant Data Meta-analysis.

Anesthesiology·2026

相关实验视频

Updated: Jun 28, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

与临床和血栓性风险因素相关的复发性静脉血栓栓塞的发生率:前性队列研究.

Trevor Baglin1, Roger Luddington, Karen Brown

  • 1Department of Haematology, Addenbrooke's NHS Trust, Cambridge, UK. tpb20@cam.ac.uk

Lancet (London, England)
|August 23, 2003
PubMed
概括

临床风险因素,而不是血栓友测试,预测在第一次发作后复发的静脉血栓栓塞 (VTE). 手术后静脉瘤患者的复发风险较低.

科学领域:

  • 血液学 血液学 血液学
  • 心血管医学 心血管医学
  • 临床风险分层的临床风险分层

背景情况:

  • 确定第一次静脉血栓栓塞 (VTE) 事件后复发的风险对于指导抗凝药治疗持续时间至关重要.
  • 临床风险因素和用于遗传性血栓性缺陷的实验室检测是VTE复发风险分层的潜在工具.

研究的目的:

  • 研究与临床风险因素和遗传性血栓性缺陷有关的VTE复发的发生率.
  • 评估血栓友爱测试在停止抗凝药治疗后对静脉瘤复发的预测价值.

主要方法:

  • 一组570名未经选择的患者的前性随访,首次客观证明了VTE.
  • 排除患有恶性疾病和抗脂综合征的患者.
  • 为所有符合条件的患者提供对遗传性血栓性缺陷的测试.

主要成果:

  • 2年后累计VTE复发率为11%,在未引起的VTE (19.4%) 后观察到的发病率最高,在手术相关的VTE (0%) 后观察到的发病率最低.
  • 复发率与遗传性血栓友病的实验室证据存在或不存在没有显著的关联 (HR 1.50,p=0.187).
  • 在患有未引起或非手术触发性静脉动脉突发症的患者中,复发率在患有或没有血栓友爱的人之间没有差异.

结论:

相关实验视频

Last Updated: Jun 28, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

  • 针对遗传性血栓性血栓症的标准实验室检测不能预测未被选择的患者在停止抗凝药治疗后的前两年内复发的静脉血栓性血栓性损伤.
  • 评估与最初VTE发作相关的临床风险因素是复发风险的可靠预测指标.
  • 经历了手术后静脉动脉突发症的患者表现出复发的风险非常低.